72P Cemiplimab monotherapy for first-line advanced NSCLC patients with PD-L1 expression ≥50%: 6-y outcomes of EMPOWER-Lung 1


Gogishvili M., Kilickap S., Baramidze A., Sezer A., Özgüroğlu M., Gumus M., ...More

ESMO OPEN, vol.11, pp.1, 2026 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 11
  • Publication Date: 2026
  • Doi Number: 10.1016/j.esmoop.2026.106379
  • Journal Name: ESMO OPEN
  • Journal Indexes: Scopus, Science Citation Index Expanded (SCI-EXPANDED), EMBASE, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.1
  • Istanbul University-Cerrahpasa Affiliated: No